ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,594Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 151

$560K Total Retail Price of All Prescriptions

Rank: 47 out of 151

845 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 845 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 845 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 7,809 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 639 458 S3 1 10
SIMVASTATIN 375 324 2 1
LEVOTHYROXINE SODIUM 311 248 3 2
FUROSEMIDE 292 245 4 6
LISINOPRIL 281 234 5 5
AMLODIPINE BESYLATE 267 231 6 3
OMEPRAZOLE 261 199 7 4
GABAPENTIN 251 160 8 14
METOPROLOL TARTRATE 251 218 8 7
ZOLPIDEM TARTRATE 175 98 10 17
METFORMIN HCL 154 106 11 8
HYDROCHLOROTHIAZIDE 144 102 12 13
MELOXICAM 142 98 13 57
CITALOPRAM HBR 121 73 14 18
SERTRALINE HCL 114 89 15 25
POTASSIUM CHLORIDE 106 87 16 19
WARFARIN SODIUM 106 87 16 9
PAROXETINE HCL 100 78 18 54
OXYCODONE HCL 99 20 S2 19 67
DONEPEZIL HCL 96 90 20 15
CLOPIDOGREL 96 88 20 29
PLAVIX 95 85 22 37
METOPROLOL SUCCINATE 95 76 22 21
FENOFIBRATE 93 53 24 61
OXYCODONE HCL-ACETAMINOPHEN 92 42 S2 25 122
CARISOPRODOL 91 28 R 26 141
FLUTICASONE PROPIONATE 89 66 27 35
ATORVASTATIN CALCIUM 88 79 28 16
ROPINIROLE HCL 85 46 29 145
ATENOLOL 85 78 29 11
CLONIDINE HCL 83 62 31 52
GLIPIZIDE 78 64 32 43
VERAPAMIL ER 70 53 33 112
CYCLOBENZAPRINE HCL 69 27 R 34 126
MORPHINE SULFATE ER 68 30 S2 35 155
ALLOPURINOL 67 55 36 42
TRAMADOL HCL 67 59 36 24
PRAVASTATIN SODIUM 66 52 38 23
CIPROFLOXACIN HCL 64 46 39 51
TIZANIDINE HCL 62 46 40 167
ALPRAZOLAM 59 35 41 41
TRAZODONE HCL 58 37 42 48
MIRTAZAPINE 57 54 43 28
ADVAIR DISKUS 56 53 44 46
TAMSULOSIN HCL 55 48 45 30
NEXIUM 54 28 46 44
NAMENDA 53 53 47 20
ISOSORBIDE MONONITRATE ER 53 49 47 55
PROMETHAZINE HCL 52 23 R 49 192
LOVASTATIN 51 26 50 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.